Pancreatic Cancer Research

ResearcherWestern UniversityActive in the last 2 years

Daniel Adam Breadner

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5379-7621; OpenAlex author ID A5009558205. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper

Papers 2

  1. Survival benefit of neoadjuvant FOLFIRINOX for patients with borderline resectable pancreatic cancer. Co-author DOI 10.14701/ahbps.23-107↗
  2. Near 5-year survival in metastatic pancreatic cancer patient with ROS1 rearrangement, HER2 amplification, and KRAS G12C mutation-a case report. Last author DOI 10.21037/jgo-23-190↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kaan Y. Balta · 1 shared paper, 2023 · strength 0.26
  2. Evelyn V. Waugh · 1 shared paper, 2024 · strength 0.22
  3. Ephraim Shin-Tian Tang · 1 shared paper, 2024 · strength 0.22
  4. Anton I. Skaro · 1 shared paper, 2024 · strength 0.22
  5. Juan Glinka · 1 shared paper, 2024 · strength 0.22
  6. Ken A. Leslie · 1 shared paper, 2024 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.